Gender, sex, and HIV: How well are we addressing the imbalance?

Current Opinion in HIV and AIDS

Volumn 3, Issue 4, 2008, Pages 514-520

  Hankins, Catherine ^a  

^a UNAIDS   (Switzerland)

Author keywords

Gender; HIV prevention; Sex; Treatment; Trials

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; DARUNAVIR PLUS RITONAVIR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; VALACICLOVIR;

ANTIVIRAL THERAPY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DISEASE COURSE; EPIDEMIC; FOOD AVAILABILITY; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INHERITANCE; LOW DRUG DOSE; POVERTY; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW; SEX DIFFERENCE; SEXUAL BEHAVIOR;

EID: 67649574153     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32830136b4     Document Type: Review

References (67)

1. Department of Gender and Women Health. Integrating gender into HIV/AIDS programmes. Geneva: World Health Organization; 2003. http://www.who.int/ gender/hiv-aids/hivaids1103.pdf. [Accessed 3 April 2008]
2. UNAIDS. AIDS Epidemic Update: December 2007. Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization; 2007.
3. Lin K, McElmurry BJ, Christiansen C. Women and HIV/AIDS in China: gender and vulnerability. Health Care Women Int 2007; 28:680-699.
4. Cohen MS. Preventing sexual transmission of HIV. Clin Infect Dis 2007; 45 (Suppl 4):S287-S292. This article reviews the role of viral load, types of sexual activity, amplifying factors such as sexually transmitted infections, and innate and genetic defences of the uninfected partner to help identify critical targets for HIV prevention.
5. UNAIDS/WHO. Report on the Global AIDS Epidemic, Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization; 2006.
6. Marston C, King E. Factors that shape young people's sexual behaviour: a systematic review. The Lancet 2006; 368:1581-1585.
7. Underhill K, Montgomery P, Operario D. Sexual abstinence only programmes to prevent HIV infection in high income countries: systematic review. BMJ 2007; 335:248.
8. Diiorio C, McCarty F, Denzmore P, Landis A. The moderating influence of mother-adolescent discussion on early and middle African-American adolescent sexual behavior. Res Nurs Health 2007; 30:193-202.
9. Aronowitz T, Todd E, Agbeshie E, Rnnels RE. Attitudes that affect the ability of African American preadolescent girls and their mothers to talk openly about sex. Ment Health Nurs 2007; 28:7-20.
10. Jarama SL, Belgrave Z, Bradford J, et al. Family, cultural and gender role aspects in the context of HIV risk among African American women of unidentified HIV status: and exploratory quantitative study. AIDS Care 2007; 19:307-317.
11. Jones R, Oliver M. Young urban women's patterns of unprotected sex with men engaging in HIV risk behaviors. AIDS Behav 2007; 11:812-821.
12. Weiser SD, Leiter K, Bangsberg DR, et al. Food insufficiency is associated with high-risk sexual behavior among women in Botswana and Swaziland. PLoS Med 2007; 4:1589-1597. The authors found food insufficiency to be associated with risk of HIV exposure and demonstrate why supporting women's subsistence farming and enhancing their control over their food supplies are key to preventing HIV acquisition and improving their resilience to HIV.
13. Kalichman SC, Simbayi LC, Kagee A, et al. Associations of poverty, substance use, and HIV transmission risk behaviors in three South African communities. Soc Sci Med 2006; 62:1641-1649.
14. UNAIDS. Presentation of policy Guidance to address gender issues. Geneva: UNAIDS/PCB; 2007.
15. Obaid TA. No woman should die giving life. Lancet 2007; 370:1287-1288. This paper was among those included in a theme issue of the Lancet focused on the Millennium Development Goal 5 and launched at the Women Deliver Conference held in October 2007.
16. Dunkle KL, Jewkes R. Effective HIV prevention requires gender-transformative work with men. Sex Transm Inf 2007; 83:173-174.
17. Dunkle KL, Jewkes R, Nduna M, et al. Transactional sex with casual and main partners among young South African men in the rural Eastern Cape: prevalence, predictors, and associations with gender-based violence. Soc Sci Med 2007; 65:1235-1248. The authors describe four different types of transaction and demonstrate that giving and receiving material goods in unequal sexual relationships can be manipulative, reinforcing power imbalances, with a strong and consistent association with perpetration of gender-based violence.
18. Moreno CL. The relationship between culture, gender, structural factors, abuse, trauma, and HIV/AIDS for Latinas. Qual Health Res 2007; 17: 340-352.
19. Silverman JG, Decker MR, Kapur NA, et al. Violence against wives, sexual risk and sexually transmitted infection among Bangladeshi men. Sex Transm Infect 2007; 83:211-215.
20. Kiarie JN, Farquhar C, Richardson BA, Kabura MN, et al. Domestic violence and prevention of mother-to-child transmission of HIV-1. AIDS 2006; 20:1763-1769.
21. Gielen AC, Ghandour RM, Burke JG, et al. HIV/AIDS and intimate partner violence: intersecting women's health issues in the United States. Trauma Violence Abuse 2007; 8:178-198.
22. Keeton C. Changing men's behaviour can improve women's health. Bull World Health Organ 2007; 85:505-506.
23. Barker G, Ricardo C, Nascimento M. Engaging men and boys in changing gender-based inequity in health: evidence from programme interventions. Geneva: World Health Organization; 2007. http://www.who.int/gender/ documents/Engaging- men-boys.pdf. [Accessed 3 April 2008]
24. Jewkes RK, Nduna M, Levin J, et al. Evaluation of Stepping Stones: a gender-transformative HIV prevention intervention. Pretoria: Medical Research Council; 2007.
25. Kim JC, Watts CH, Hargreaves JR, et al. Understanding the impact of a microfinance-based intervention on women's empowerment and the reduction of intimate partner violence in South Africa. Am J Public Health 2007; 97:1794-1802. This randomized controlled trial, which combined a microfinance programme with participatory training on understanding HIV infection, gender norms, domestic violence and sexuality, resulted in a reduction by more than half in intimate partner physical or sexual violence after 2 years.
26. Grown C, Gupta GR, Pande R. Taking action to improve women's health through gender equality and women's empowerment. Lancet 2005; 365:541-543.
27. Nour NM. Health consequences of child marriage in Africa. Emerg Infect Dis 2006; 12:1644-1649.
28. Bongaarts J. Late marriage and the HIV epidemic in sub-Saharan Africa. Popul Stud (Camb) 2007; 61:73-83.
29. UNAIDS. Review of progress Secretary-General Task Force on Women, Girls and HIV/AIDS in Southern Africa. Geneva: UNAIDS/PCB; 2007.
30. Mantell JE, Dworkin SL, Exner TM, et al. The promises and limitations of female-initiated methods of HIV/STI protection. Soc Sci Med 2006; 63: 1998-2009.
31. Scott-Sheldon LA, Glasford DE, Marsh KL, Lust SA. Barriers to condom purchasing: Effects of product positioning on reactions to condoms. Soc Sci Med 2006; 63:2755-2769.
32. Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. New York: International Harm Reduction Development Program of the Open Society Institute; 2007.
33. Hankins C. Sex, drugs, and gender? High time for lived experience to inform action. Int J Drug Policy 2008; 19:95-96.
34. Nothing about us without us: greater, meaningful involvement of people who use illegal drugs. Toronto: Canadian HIV/AIDS Legal Network; 2005.
35. Cockcroft A, Andersson N, Milne D, et al. Community views about routine HIV testing and antiretroviral treatment in Botswana: signs of progress from a cross sectional study. BMC Int Health Hum Rights 2007; 87:5.
36. Kumar A, St White H, Carter AO. Trends in the uptake of antenatal voluntary counselling and testing for HIV and HIV prevalence among childbearing women in Barbados, 1993-2004: evidence to gauge the effectiveness of HIV prevention measures. West Indian Med J 2007; 56:60-65.
37. Balkus J, Bosire R, John-Stewart G, et al. High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya. Sex Transm Dis 2007; 34:25-29.
38. Napravnik S, Poole C, Thomas JC, Eron JJ Jr. Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr 2002; 31:11-19.
39. Otieno PA, Brown ER, Mbori-Ngacha DA, et al. HIV-1 disease progression in breast-feeding and formula-feeding mothers: A prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis 2007; 195:220-229.
40. World Health Organization. Review of priorities in research on hormonal contraception and IUDs and HIV infection. Report of a technical meeting, March 2007. Geneva: World Health Organization; 2007.
41. Kleinschmidt I, Rees H, Delany S, Smith D, et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007; 75:461-467.
42. WHO/UNAIDS. Progress on global access to antiretroviral therapy: 3 by 5 and beyond. Geneva: WHO/UNAIDS; 2006.
43. Muula AS, Ngulube TJ, Siziya S, et al. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 2007; 7:63. This systematic review found that the majority of reports had a female to male ratio exceeding 1.6 to 1, which was not solely explained by higher HIV prevalence among women than men. More research is needed to better understand the factors facilitating women's access to HIV treatment.
44. Braitstein P, Boulle A, Nash D, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 2008; 17:47-55.
45. Nicastri E, Leone S, Angeletti C, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 2007; 60:724-732. This review spanning 2002 to 2007 of sex differences in the impact of antiretroviral treatment found that studies were underpowered to detect sex differences and had limited follow-up of 6 to 12 months. Women were more likely to have nonstructured treatment interruptions than men.
46. Penniman TV, Taylor SL, Bird CE, et al. The associations of gender, sexual identity and competing needs with healthcare utilization among people with HIV/AIDS. Journal of the International Medical Association 2007; 99:419-427.
47. Fardet L, Mary-Krause M, Partisani M, et al. Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response. HIV medicine 2006; 7:520-529.
48. Stipzer DL, Steward MJ, Gray J, et al. Gender and sex-based analysis in health research: a guide for CIHR researchers and reviewers. Ottawa: Canadian Institutes of Health Research; 2007.
49. Berger J, Roncaglioni M, Avanyini JF, et al. Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295:306-313.
50. Clinical trials: http://clinicaltrials.gov/ Search: women AIDS therapeutic trials versus men AIDS therapeutic trials. [Accessed 10 February 2008].
51. Wassenaar DR, Barsdorf NW. The ethical involvement of women in HIV vaccine trials in Africa: discussion paper developed for the African AIDS Vaccine Programme. Women Health 2007; 45:37-50.
52. UNAIDS. Women and adolescent girls' participation in HIV trials. A background paper for the conference "Making HIV trials work for women and adolescent girls"; 10-11 December 2007; Geneva, Switzerland. Geneva: UNAIDS; 2007.
53. HVTN 2007. Information regarding trials using the MRK Ad5 gag/pol/ nef Vaccine. http://www.hvtn.org/media/pr/step1207.html. [Accessed 19 February 2008]
54. Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007; 2:e27.
55. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007; 196:1500-1508.
56. UNAIDS/WHO. Ethical considerations for biomedical HIV prevention trials. Geneva: Joint United Programme on HIV/AIDS; 2007.
57. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
58. Bailey C, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 2007; 369:643-656.
59. Gray H, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in young men in Rakai, Uganda: a randomized trial. Lancet 2007; 369:657-666.
60. Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav 2007; 11:341-355.
61. WHO/UNAIDS. Newdata on male circumcision and HIV prevention: policy and programme implications: conclusions and recommendations. Geneva: WHO, UNAIDS; 2007. http://www.ibe.unesco.org/AIDS/doc/MC-Policy-and-Programme- Recommendations.pdf. [Accessed 3 April 2008]
62. Hankins C. Male circumcision: implications for women as sexual partners and parents. Reprod Health Matters 2007; 15:62-67.
63. Turner AN, Morrison CS, Padian NS, et al. Men's circumcision status and women's risk of HIV acquisition in Zimbabwe and Uganda. AIDS 2007; 21: 1779-1789.
64. Rakai Health Sciences Program. Study presents new information on male circumcision to prevent spread of HIV in Africa. Press release, 6 March 2007. Rakai: Rakai Health Sciences Program; 2007.
65. th Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008; Boston. Alexandria: CROI; 2008. Paper 33LB.
66. Moodley K. Microbicide research in developing countries: have we given the ethical concerns due consideration? BMC Med Ethics 2007; 8:10.
67. Shiffman J, Smith S. Generation of political priority for global health initiatives: a framework and case study of maternal mortality. Lancet 2007; 370:1370-1379. This article proposes four categories of a framework to analyse why some global health initiatives receive priority: the strength of the actors, the power of the ideas, the nature of the policy contexts, and characteristics of the issue itself.